Web site spotlight: Preventing the spread of vancomycin-resistant enterococci
Staff Development Weekly: Insight on Evidence-Based Practice in Education, June 26, 2008
Want to receive articles like this one in your inbox? Subscribe to Staff Development Weekly: Insight on Evidence-Based Practice in Education!
Vancomycin-resistant enterococci (VRE) spends far less time in the spotlight than other multidrug-resistant organisms (MDROs), particularly MRSA. Although this organism may be less pathogenic than some of its more famous counterparts, it still poses a serious concern for healthcare facilities. Not only does VRE cause complications for already sick patients, resulting in longer stays and higher costs, but there is another concern-chiefly that it will meet with MRSA in a co-colonized patient and mutate, spreading vancomycin-resistant Staphylococcus aureus (VRSA), says Connie Steed, RN, BSN, CIC, manager of IC at the Greenville (SC) Hospital System.
Assessing your facility's risk
VRE was first reported in U.S. hospitals in 1989. By 2004, data showed that VRE caused about one-third of infections in hospital ICUs, the CDC states. According to the CDC, VRE infections most commonly occur in patients who:
- Are treated with vancomycin and combinations of other antibiotics, such as penicillin and gentamicin
- Receive antibiotic treatment for long periods of time
- Have weakened immune systems, such as patients in ICUs or in cancer or transplant wards
- Have had surgery, such as abdominal or chest surgery
- Use medical devices, such as urinary catheters or central intravenous catheters, that stay in for a long period of time
Editor's note: This excerpt was taken from the article "Strategies to prevent the spread of vancomycin-resistant enterococci in your facility," found in the Reading Room at www.StrategiesForNurseManagers.com. Get a free trial membership that will give you 30 days to test drive all the exciting features on the Web site.
Want to receive articles like this one in your inbox? Subscribe to Staff Development Weekly: Insight on Evidence-Based Practice in Education!
Comments
0 comments on “Web site spotlight: Preventing the spread of vancomycin-resistant enterococci ”
Related Products
Most Popular
- Articles
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Topic: CMS, OESS post new security compliance review information, checklist
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Answering service messages
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- OB services: Coding inside and outside of the package
- CMS issues IPPS proposed rule for FY 2013
- The debate continues: Nurses who reported physician to the Texas Medical Board file federal appeal
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Are your workforce members texting PHI?
- Don't let these sentinel events trigger falsely
- Arkansas woman convicted for HIPAA violation
- Q&A: Coding for protein malnutrition
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Searched
